TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 8 | 11 | 3 | -22 | -44 | -78 | -20 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/28/13 21:26 | 10/22/13 | ADXS | Advaxis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moore Thomas A | NJ | D | M.d | 163 | 4.00 | 1 | 41 | 33 | 165 | D | -80 | -37 | -58 | 8 | -43 | -21 | -28 | 0 | 4 | -1 | 1 | 31 | -34 | -10 | |
10/26/07 10:05 | 10/23/07 | ADXS | Advaxis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moore Thomas A | NJ | DO | CB , CEO | P.d | 400 | 0.1500 | 0 | 2,667 | New | 2,667 | D | -28 | -17 | -47 | -28 | 7 | -31 | -22 | -16 | 8 | 11 | 3 | -22 | -44 | -78 |
8/11/03 16:07 | 8/7/03 | BPUR | Biopure Corp | DE | Health | BioPrd | Biological Products, (No Diag | Moore Thomas A | DO | P,CEO | S | -21 | 2.42 | 0 | -9 | -3 | 323 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |